Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yorimitsu

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Acta Medica Okayama|June 1, 1986
Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemiaI Takahashi, S Yorimitsu, M Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Therapeutic results of 43 cases of adult acute lymphocytic leukemia]I Kimura, K Kitajima, I Takahashi, et al.
The Japanese Journal of Antibiotics|June 1, 1979
[Experience in combination therapy with amikacin, mainly by intravenous drip infusion of a large dose, for infections in acute leukaemia patients (author's transl)]F Koui, M Y Rai, S Yorimitsu, et al.
Gan|February 1, 1981
A variant translocation (8;22) in a Japanese patient with Burkitt lymphomaI Miyoshi, K Hamazaki, I Kubonishi, et al.
Acta Medica Okayama|November 1, 1980
Treatment of refractory acute leukemia with aclacinomycin-AI Takahashi, M Hara, T Adachi, et al.
Acta Medica Okayama|February 1, 1982
Treatment of relapsed acute myelocytic leukemia with a combination of aclarubicin and cytosine arabinosideI Takahashi, M Hara, K Uchida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1983
[Clinical studies on superoxide production of neutrophils in patients with acute leukemia]F Koui, E Ohmoto, Y Oda, et al.
International Journal of Hematology|October 20, 2000
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysisT Okamoto, A Kanamaru, C Shimazaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1982
[Clinical management of acute lymphocytic leukemia in adults. 1. Treatment of acute lymphocytic leukemia with VP (vincristine, prednisolone)--DVMP (daunorubicin, vincristine 6-mercaptopurine, prednisolone) regimen]I Takahashi, K Uchida, E Ohmoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1982
[Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia]I Takahashi, M Hara, E Ohmoto, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Acta Medica Okayama|June 1, 1986
Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemiaI Takahashi, S Yorimitsu, M Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Therapeutic results of 43 cases of adult acute lymphocytic leukemia]I Kimura, K Kitajima, I Takahashi, et al.
The Japanese Journal of Antibiotics|June 1, 1979
[Experience in combination therapy with amikacin, mainly by intravenous drip infusion of a large dose, for infections in acute leukaemia patients (author's transl)]F Koui, M Y Rai, S Yorimitsu, et al.
Gan|February 1, 1981
A variant translocation (8;22) in a Japanese patient with Burkitt lymphomaI Miyoshi, K Hamazaki, I Kubonishi, et al.
Acta Medica Okayama|November 1, 1980
Treatment of refractory acute leukemia with aclacinomycin-AI Takahashi, M Hara, T Adachi, et al.
Acta Medica Okayama|February 1, 1982
Treatment of relapsed acute myelocytic leukemia with a combination of aclarubicin and cytosine arabinosideI Takahashi, M Hara, K Uchida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1983
[Clinical studies on superoxide production of neutrophils in patients with acute leukemia]F Koui, E Ohmoto, Y Oda, et al.
International Journal of Hematology|October 20, 2000
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysisT Okamoto, A Kanamaru, C Shimazaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1982
[Clinical management of acute lymphocytic leukemia in adults. 1. Treatment of acute lymphocytic leukemia with VP (vincristine, prednisolone)--DVMP (daunorubicin, vincristine 6-mercaptopurine, prednisolone) regimen]I Takahashi, K Uchida, E Ohmoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1982
[Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia]I Takahashi, M Hara, E Ohmoto, et al.
Pageof 4